These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 17039953)
21. The use, misuse, and abuse of design controls. Samaras GM IEEE Eng Med Biol Mag; 2010; 29(3):12-8. PubMed ID: 20659853 [TBL] [Abstract][Full Text] [Related]
22. Pharmaceuticals and medical devices: medical devices. Year end issue brief. Tiffany S Issue Brief Health Policy Track Serv; 2008 Jan; ():1-19. PubMed ID: 18345548 [No Abstract] [Full Text] [Related]
23. The new FDA combination products programme. Donawa M Med Device Technol; 2002 Oct; 13(8):25-8. PubMed ID: 12416330 [TBL] [Abstract][Full Text] [Related]
24. Medical devices; effective date of requirement for premarket approval for three preamendment class III devices. Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Apr; 65(72):19833-4. PubMed ID: 11010634 [TBL] [Abstract][Full Text] [Related]
25. US and European postmarket clinical data requirements. Donawa M Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495 [TBL] [Abstract][Full Text] [Related]
27. The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation? Fargen KM; Frei D; Fiorella D; McDougall CG; Myers PM; Hirsch JA; Mocco J J Neurointerv Surg; 2013 Jul; 5(4):269-75. PubMed ID: 22764203 [No Abstract] [Full Text] [Related]
28. How do regulatory agencies ensure the release of a safe medical device? Haggar B Clin Perform Qual Health Care; 1999; 7(2):100-3. PubMed ID: 10747561 [TBL] [Abstract][Full Text] [Related]
29. [Standards used in the regulation of medical device in USA]. Hu W; Gu H Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Nov; 21(11):1263-7. PubMed ID: 18069490 [TBL] [Abstract][Full Text] [Related]
30. Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications. Lee SJ; Cho L; Klang E; Wall J; Rensi S; Glicksberg BS JAMA Netw Open; 2021 Jun; 4(6):e2112562. PubMed ID: 34156454 [TBL] [Abstract][Full Text] [Related]
31. Managing changes during a clinical investigation, Part I. Donawa M Med Device Technol; 2003 Sep; 14(7):31-3. PubMed ID: 14528812 [TBL] [Abstract][Full Text] [Related]
33. Devices and the food and drug administration. Phillips SJ; Phillips RS Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210 [No Abstract] [Full Text] [Related]
34. Left to their own devices: breakdowns in United States medical device premarket review. Hines JZ; Lurie P; Yu E; Wolfe S PLoS Med; 2010 Jul; 7(7):e1000280. PubMed ID: 20634922 [TBL] [Abstract][Full Text] [Related]
35. Use of standards in the review of medical devices. Ho C; Jensen D; Lacy F; Muni N; Reilly S; Mallis E J Electrocardiol; 2005 Oct; 38(4 Suppl):171-4. PubMed ID: 16226095 [TBL] [Abstract][Full Text] [Related]
36. Addressing US and European device testing requirements. Donawa M Med Device Technol; 2008 Sep; 19(5):32, 34-7. PubMed ID: 18947148 [TBL] [Abstract][Full Text] [Related]
37. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment. Food and Drug Administration. HHS Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800 [TBL] [Abstract][Full Text] [Related]
38. Beyond the US submisson process. Donawa M Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536 [TBL] [Abstract][Full Text] [Related]
39. The regulation of home diagnostic tests for genetic disorders: can the FDA deny a premarket application on the basis of the device's social impacts? Kerouac JD J Biolaw Bus; 2002; 5(1):34-43. PubMed ID: 12751500 [TBL] [Abstract][Full Text] [Related]
40. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr. Jarcho DG Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]